Most Recent Analysts Ratings Valeant Pharmaceuticals International, Inc. (VRX)

24 July, 2017, 14:09 | Author: Pamela Mathis

Pershing Square Capital Management - L.P. also sold $199.26 million worth of Valeant Pharmaceuticals Intl Inc (TSE:VRX) shares. Valeant Pharmaceuticals Intl had 112 analyst reports since July 21, 2015 according to SRatingsIntel. (VRX) stock moved with shift of 1.79% in the past week. On average, analysts expect that Valeant Pharmaceuticals International, Inc. will post $3.89 EPS for the current year.

Analysts await Banco Macro SA (ADR) (NYSE:BMA) to report earnings on August, 8.

06/09/2017 - Valeant Pharmaceuticals International, Inc. had its " rating reiterated by analysts at Canaccord Genuity.

Valeant Pharmaceuticals International, Inc. closed its last trading session at $17.25 with the gain of 2.03%. The specialty pharmaceutical company reported $2.80 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.87 by $1.93. According to these analysts, the Low Revenue Estimate for Valeant Pharmaceuticals International, Inc.is 270.8 Million and the High Revenue Estimate is 333 Million. During the same period in the previous year, the firm earned ($1.08) earnings per share. The company had Year Ago Sales of 220.32 Million.

A number of brokerages have issued reports on VRX. Guggenheim started coverage on shares of Valeant Pharmaceuticals International in a research note on Saturday, June 17th.

On December 15 the stock rating was downgraded to "Equal-Weight" from "Neutral" and a price target of $17.00 was set in a report issued by Morgan Stanley. BidaskClub downgraded shares of Valeant Pharmaceuticals International from a "hold" rating to a "sell" rating in a research note on Friday, June 16th. Finally, Wells Fargo & Company reaffirmed a "sell" rating on shares of Valeant Pharmaceuticals International in a research report on Tuesday, June 27th.

The Destiny 2 open beta has been extended
While the beta was initially set to end yesterday, it is now being extended a few extra days to give more people the opportunity to jump in.


Among 10 analysts covering Guidewire Software (NYSE:GWRE), 8 have Buy rating, 0 Sell and 2 Hold. $51.78's average target is 194.20% above currents $17.6 stock price. Goldman Sachs Grp Inc holds 0% or 35,101 shares in its portfolio. Trading volume was down 75.52% under the stocks average daily volume.

Private Management Group Inc increased Valeant Pharmaceuticals Intl (VRX) stake by 91.02% reported in 2016Q4 SEC filing. The firm's market cap is $6.12 billion. The firm has a 50 day moving average of $13.59 and a 200-day moving average of $12.98.

In related news, Director Schutter Richard U. De bought 20,000 shares of the business's stock in a transaction on Thursday, May 11th. Total Debt/Equity is 714.85 and the Book value per Share is 11.19. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Institutional owners hold 66.80% stake in the company while Insiders ownership held at 2.30%.

The stock is now showing YTD performance of 21.21 Percent. Harbor Advisors LLC acquired a new stake in Valeant Pharmaceuticals International during the first quarter worth about $110,000. The original version of this article can be read at https://www.baseball-news-blog.com/2017/07/22/td-securities-increases-valeant-pharmaceuticals-intl-inc-tsevrx-price-target-to-c26-00-updated.html. Financial Architects Inc now owns 9,550 shares of the specialty pharmaceutical company's stock valued at $105,000 after buying an additional 1,500 shares during the last quarter. Finally, NEXT Financial Group Inc raised its stake in shares of Valeant Pharmaceuticals International by 6.2% in the second quarter. The RSI computes momentum as the ratio of higher closes to lower closes: stocks which have had more or stronger positive changes have a higher RSI than stocks which have had more or stronger negative changes. OppenheimerFunds Inc. increased its stake in Valeant Pharmaceuticals International by 17.1% in the first quarter. More interesting news about Valeant Pharmaceuticals Intl Inc (NYSE:VRX) were released by: Investorplace.com and their article: "Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Seeing a Lot of Quiet Buying" published on July 10, 2017 as well as Seekingalpha.com's news article titled: "Valeant: Much More Upside Remains" with publication date: July 12, 2017. Morgan Stanley now owns 2,777,063 shares of the specialty pharmaceutical company's stock worth $30,631,000 after buying an additional 903,256 shares in the last quarter. The fund owned 633,787 shares of the specialty pharmaceutical company's stock after selling 7,951 shares during the period. The Virginia-based Thompson Davis has invested 0.01% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).

Recommended:



Popular

Kyle Busch, Martin Truex Jr. wreck while battling for lead at Indianapolis
The two had run 1-2 virtually all afternoon and easily worked through traffic when they weren't several seconds ahead of the pack. Their latest restart, however, they made a decision to race for the win, throwing their manufacturer alliance out the window.

Cristiano Ronaldo Names His Main Competitors for the Ballon d'Or Next Season
Real Madrid forward Cristiano Ronaldo says that the fear of being surpassed as the leading player in world football allows him to continue at the top of his game.

Dollar struggles near 13-month low amid Trump-related turbulence
The euro was underpinned by expectations that the European Central Bank is moving closer to tapering its bond-buying program. Oil prices dipped, adding to Friday's 2.5 percent fall, before a meeting of OPEC nations and other producers.

Antonio Conte: Chelsea winger Pedro has suffered multiple fractures
Pedro forced out of Chelsea tour with concussion & facial injuries after collision with David Ospina . He stayed overnight in hospital for observation and will now head back to London for further review.

The Targa Resources, Inc. (NYSE:TRGP) Raised to Hold at ValuEngine
The fund owned 6,947 shares of the pipeline company's stock after buying an additional 1,400 shares during the period. The stock of Unum Group (NYSE:UNM) has "Outperform" rating given on Wednesday, February 3 by RBC Capital Markets.

Lincoln National Corporation (NYSE:LNC) Reviewed By Analysts
Lincoln National Corporation (NYSE:LNC) has a market cap of $16.06 billion and over the last 12 months, LNC has risen by 64.35%. The insider Buckingham Lisa sold $2.09M. $163,292 worth of Lincoln National Corporation (NYSE:LNC) was sold by Solon Kenneth S.

Westinghouse Air Brake Technologies Corporation (NYSE:WAB) Receives An Update From Brokers
Commerzbank Aktiengesellschaft Fi reported 3,512 shares or 0% of all its holdings. 4,952 are held by Fifth Third Natl Bank. The stock of Global Blood Therapeutics Inc (NASDAQ:GBT) has "Outperform" rating given on Tuesday, September 8 by Wedbush.

Rhino poaching deaths down - Minister Molewa
Minister Molewa will be joined by security cluster ministers. Molewa said the poachers were now also targeting elephants. This is compared to 354 in the same period in 2016.

2 children seriously injured in NC near-drowning
Crews responded at around 6 p.m.to the Vista Villa Apartments in the 6300 block of Montego Drive. An 8-year-old girl is dead after drowning at an east Charlotte apartment's swimming pool.

'Gowda made Hindi speech, but didn't know what he said'
A script, which of course, made no sense to him", said Tharoor.He claimed that such an episode is nearly impossible elsewhere. In any case we canuse English as a communication across the country.